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Research Article
Endotracheal tube-induced sore throat pain
and inflammation is coupled to the release
of mitochondrial DNA
Carlos A Puyo1, Daniela Peruzzi2,3, Alexander Earhart1,
Evan Roller1, Menelaos Karanikolas1, Marin H Kollef5,
Alexander S Krupnick2,4, Daniel Kreisel2, Mohsen Ibrahim2,3 and
Andrew E Gelman2,3
Abstract
In the absence of infection, the pathophysiology of endotracheal tube-induced sore throat pain is unclear. Activated neu-
trophils release elastase, reactive oxygen species, and inflammatory cytokines known to contribute to neuropathic pain.
Sterile tissue injury can cause the release of damage-associated molecular patterns such as mitochondrial DNA that promote
neutrophil activation. We hypothesized that endotracheal tube-induced sore throat pain is linked to mitochondrial DNA-
mediated neutrophil inflammation. A nonrandomized prospective survey for sore throat pain was conducted in 31 patients
who required short-term intubation and had no evidence of upper airway infection. Patterns of neutrophil abundance,
activation, and mitochondrial DNA levels were analyzed in tracheal lavage fluid following intubation and prior to extubation.
Thirteen of 31 patients reported sore throat pain. Sore throat patients had high neutrophilia with elevated adhesion molecule
and TLR9 expression and constitutive reactive oxygen species generation. Tracheal lavage fluid from sore throat patients
accumulated mitochondrial DNA and stimulated neutrophils to release mediators associated with pain in a TLR9- and
DNAse-dependent fashion. Endotracheal tube-induced sore throat is linked to the release of mitochondrial DNA and can
drive TLR9-mediated inflammatory responses by neutrophils reported to cause pain. Mitigating the effects of cell-free
mitochondrial DNA may prove beneficial for the prevention of endotracheal tube-mediated sore throat pain.
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Introduction
Endotracheal tube (ETT) placement is commonly
associated with postoperative sore throat (POST) pain.
The incidence of POST has been reported between 20%
and 50% following ETT placement1–3 and is linked with
symptoms of upper airway discomfort such as tracheitis,
hoarseness, and dysphagia, which may delay patient
recovery after surgery.1 Several factors are implicated
in POST including ETT materials, cuﬀ pressure,
airway instrumentation, and pharmacological agents.1–3
ETT placement is also associated with the development
of pneumonia in infectious4,5 and noninfectious set-
tings.5,6 However, in the absence of infection, the under-
lying mechanisms that contribute to POST remain
unclear.
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Our previous work has shown that short-term ETT
placement results in mechanically mediated tissue injury
and induces the inﬂux of neutrophils.7,8 Previous studies
have demonstrated the link between neutrophil activation
and neuropathic pain.9,10 For example, animal studies
have highlighted the importance of neutrophil elastase
release in the induction of acute pain.10 Neutrophils also
release other proalgesic mediators, including reactive
oxygen species (ROS),11 interleukin 1 beta (IL-1b),12
and tumor necrosis factor alpha (TNF-a).13
Neutrophils can be activated by damage-associated
molecular patterns released by cells injured during
stress such as crush trauma.14 Damage-associated
molecular patterns are recognized by pattern recognition
receptors (PRRs),15 which trigger inﬂammatory
signaling pathways inducing gene expression.
Neutrophils express all major classes of PRRs including
Toll-like receptor (TLR), scavenger, and complement
receptors.16,17 In particular, TLR9 recognizes hypo-
methylated CpG DNA motifs within the bacterial
genome.18 Consistent with the bacterial ancestry of mito-
chondria, recent work has demonstrated TLR9-depen-
dent neutrophil activation in response to mitochondrial
DNA (mtDNA) released by injured cells.19 Here, we
show that tracheal lavage ﬂuid (TLF) neutrophils from
patients reporting ETT-mediated POST are activated
and contain signiﬁcantly more mtDNA than TLF from
their counterparts who do not report throat pain. In
addition, exposure of resting neutrophils to TLF




After obtaining Washington University School of
Medicine in St. Louis’ institutional review board
approval #201301037 for human studies and informed
written consent, 31 adults aged 18 to 65 years, with
American Society of Anesthesiologists health classiﬁca-
tion I/II requiring endotracheal intubation for same-day
laparoscopic gastric, gynecologic, or orthopedic
surgeries, were enrolled in this study. Multiple attempts
at intubation and any active autoimmune or pulmonary
disease, hepatitis, cancer, previous tracheal surgery,
surgery or endotracheal intubation within ﬁve days
prior, smoking history less than six weeks prior, and
immunosuppressive medication or azithromycin use
excluded patients from participation in this study.
Specimen collection
After the placement of MallinckrodtTM TaperGuard
Evac ETTs (7mm internal diameter for females and
8mm for males), two tracheal lavage samples were
obtained from each patient: immediately following
intubation and prior to extubation. Wall suction was
utilized to collect specimens, and neutrophils were imme-
diately isolated using EasySepTM Neutrophil Enrichment
Kits (StemCell Technologies, Vancouver, Canada) per
manufacturer’s instructions. Two hours postsurgery,
the presence or absence of sore throat pain was
documented.
Neutrophil TLF phenotyping
Isolated neutrophils were stained with anti-human
monoclonal antibodies for CD16 (clone B73.1) and
CD66b (clone G10F5) for population identiﬁcation,
and CD11b (clone ICRF44), CD54 (clone HA58), and
TLR9 (clone eB72-1665) as adhesion and activity
markers, and subsequently characterized by ﬂuores-
cence-activated cell sorting (FACS; FACScan DxP10,
BD Biosciences, San Jose, CA). Respiratory burst was
analyzed by priming CD16/CD66b-stained neutrophils
with 10 ng/mL phorbol 12-myristate 13-acetate for
10min at 37C followed by the addition of 20 mM dihy-
drorhodamine 123 for 10 s and characterized by FACS.
Thirty thousand events were analyzed with FlowJo X
software (Tree Star, Ashland, OR).
mtDNA quantitation
Primers for human MT-CYB and bacterial 16S rRNA
(Integrated DNA Technologies, Coralville, IA) were
used to identify extracellular mtDNA concentrations in
subject TLF supernatants and exclude bacterial infection
of the upper airway, respectively, by quantitative poly-
merase chain reaction (qPCR). mtDNA puriﬁed from
human A549 cell mitochondria was used to quantify
extracellular mtDNA.
Neutrophil co-culture and TLF enzyme-linked
immunosorbent assay
To replicate activation, neutrophils were isolated from
20mL blood of 51 healthy volunteers and cocultured
with TLF from subjects with or without sore throat
pain and one of either 3 mg/mL DNAse I, 30 mg/mL
DNAse I, or 1 mM inhibitory oligodeoxynucleotide
(iODN; TTAGGG A151; Invivogen, San Diego, CA);
or with 3 mM proinﬂammatory 50-C-phosphate-G-30
(CpG) ODN and either 3 mg/mL DNAse I, 30 mg/mL
DNAse I, or 1 mM iODN as controls; then incubated
at 37Cþ 5% CO2 for 6 h and then stained for FACS.
Human neutrophil elastase (HNE) activity was mea-
sured by enzymatic hydrolysis of the HNE-speciﬁc
chromogenic substrate N-methoxysuccinyl-Ala-Ala-
Pro-Val p-nitroanilide (MeO-SucAAPVpNA; Sigma
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Aldrich, St. Louis, MO) into 4-nitroaniline. Supernatants
from the experimental cocultures were incubated with
1mM MeO-SucAAPVpNA in 0.1M HEPES (pH 7.5)
buﬀer at 37Cþ 5% CO2 for 1 h. Substrate cleavage
into 4-nitroaniline by HNE was measured by absorbance
at 405nm via spectrophotometry (NanoDrop 2000,
ThermoFisher Scientiﬁc, Waltham, MA).
Primers for human IL-1, IL-8, TNF-, and TLR9
(ThermoFisher Scientiﬁc) were used to evaluate their
transcription in these cocultures. All experiments were
run on a Bio-Rad CFX 96 thermocycler and analyzed
with provided Bio-Rad CFX Manager software
(Bio-Rad Laboratories Inc, Hercules, CA). Conditions
were 95C for 5-min initialization, then 50 cycles of
95C for 30-s denaturing, 58C for 30-s annealing, and
68C for 10-s extension and subsequent plate read; fol-
lowed by melt curve analysis from 65C to 95C.
TLF IL-1, IL-8, and TNF- levels was analyzed with
enzyme-linked immunosorbent assays (ProcartaPlex
Simplex, ThermoFisher Scientiﬁc, Waltham, MA) in
accordance with manufacturers recommendations.
Cell reporter assay
A human embryonic kidney (HEK) cell line with
transfected human TLR9 and NF-kB/AP-1 alkaline
phosphatase transgenes (HEK-BlueTM hTLR9;
Invivogen) was grown and cocultured with TLF from
subjects with or without sore throat pain and one of
either 3 mg/mL DNAse I, 30 mg/mL DNAse I, or 1 mM
iODN; or with 3 mM proinﬂammatory 50-C-phosphate-
G-30 (CpG) ODN and either 3 mg/mL DNAse I,
30 mg/mL DNAse I, or 1 mM iODN as controls; at
37Cþ 5% CO2 for 6h. TLR9 activation was analyzed by
alkaline phosphatase release, measured using QUANTI-
BlueTM calorimetric detection medium (Invivogen) via
spectrophotometry.
Statistical analysis
All data were analyzed using SPSS version 17.0 (SPSS
Inc, Chicago, IL). Continuous variables obtained for
neutrophil counts in the two independent groups ‘‘Sore
Throat’’ and ‘‘No Sore Throat’’ were compared using the
Student’s t test. Continuous variables for median ﬂuor-
escence intensity for identifying activation phenotypes,
ROS production, and inﬂammatory marker secretion
between both independent groups were tested with the
Mann–Whitney U test. Categorical variables—including
mean age, gender, body mass index, hypertension, hyper-
cholesterolemia, sleep apnea status, and intubation times
in both independent groups—were compared using
Fisher’s exact test for contingency tables.
Analyses of qPCR data for determining mtDNA and
bacterial DNA concentrations were performed using a
Kruskal–Wallis test with Dunn’s post hoc test.
Inﬂammatory qPCR transcript and FACS median ﬂuor-
escence intensity data from both independent groups
treated with DNAse I and CpG ODN or iODN were
analyzed with multivariate analysis of variance com-




Thirty-one patients admitted for same-day surgery at the
Barnes Jewish Hospital without evidence of upper
respiratory infection meeting the American Society of
Anesthesiologists health classiﬁcation I/II were asked
for a ‘‘yes’’ or ‘‘no’’ response to whether they had sore
throat pain 2 h after extubation. As shown in Table 1,
nearly half of all patients reported throat pain. Risk of
sore throat was unrelated to gender, age, body mass
index, hypertension, serum cholesterol, obstructive
sleep apnea, or intubation time. However, in line with
previous studies,2,3 there was a nonsigniﬁcant bias in
female patients with 61.5% reporting sore throat.
Tracheal neutrophils in sore throat patients have an
activation phenotype
Our previous observations that ETT placement in animal
models causes tracheal mucosal injury and upper airway
neutrophilia8 led us to investigate neutrophil abundance
and activation in intubated patients. TLFs from sore
throat and nonsore throat patients at the time of intub-
ation had low and comparable numbers of neutrophils
(Figure 1). In contrast, sore throat patients prior to extu-
bation had signiﬁcantly more neutrophils in their TLF
when compared to nonsore throat patients. Neutrophils
Table 1. Patient Demographics.
Variable Sore throat Nonsore throat P
Number of patients, n 13 18 –
Age, years,
mean (range)
40.92 (26–56) 40.78 (19–61) 0.361
Female, n (%) 8 (61.64%) 7 (38.89%) 0.292
Male, n (%) 5 (38.46%) 11 (61.11%) 0.313
Body mass index,
n SEM
30.46 7.35 33.25 12.45 0.442
Hypertension, n (%) 5 (38.46%) 4 (22.22%) 0.433
Hypercholesterolemia,
n (%)
3 (23.08%) 2 (11.11%) 0.625
Sleep apnea, n (%) 2 (15.38%) 1 (5.55%) 0.558
Intubation time,
min (range)
213.38 (123–354) 174.78 (55–363) 0.395
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in sore throat TLF were also highly activated as they
constitutively produced ROS (Figure 2(a)) and had
higher adhesion molecule expression involved in gran-
ulocyte traﬃcking into extracellular spaces as evident
by higher plasma membrane levels of CD11b, CD54,
and CD66b (Figure 2(b)).
High mtDNA levels in the TLF of sore throat patients
We next analyzed mtDNA levels in the TLF and circu-
lating blood, as it is a reported mediator of neutrophil
activation in lieu of infection.14 Unlike in the circulating
blood, TLF mtDNA levels were sharply elevated in sore
throat patients when compared to patients who did not
report throat pain (Figure 3(a)). Importantly, mtDNA
concentrations in the peripheral blood and TLF of non-
sore throat patients were also similar suggesting that sur-
gery itself was not a cause of mtDNA release. 16S
ribosomal DNA, a commonly used indicator for the
presence of bacteria,20 was nearly undetectable in the
TLF of both subject groups, indicating the absence of
infection in the upper airway (Figure 3(b)). Based on
these observations, we asked if TLF neutrophils in sore
throat patients express TLR9, a PRR that recognizes
hypomethylated CpG DNA motifs found in mitochon-
dria.21 TLR9 expression in TLF neutrophils was signiﬁ-
cantly elevated in sore throat patients compared to those
without sore throat (Figure 3(c)).
Figure 2. Sore throat TLF neutrophils have a distinct activation
phenotype. TLF neutrophils were identified by FACS analysis on a
SCChi CD66blo-hi CD16lo-hi gate and evaluated for (a) ROS pro-
duction with DHR 123 dye and plasma membrane expression of
(b) CD66b, CD16, CD54, and CD11b using appropriate antibo-
dies. Data (left panel) are representative overlaid histogram result
from a sore throat and a nonsore throat patient where solid lines
represent indicated antibodies and dotted lines show respective
isotype antibody controls. Mean results (right panel) are shown as
the MFI SD derived from sore throat patients (n¼ 13) and
nonsore throat (n¼ 18) patients.
DHR, dihydrorhodamine; MFI: mean fluorescence intensity; TLF:
tracheal lavage fluid.
Figure 1. High numbers of TLF neutrophils found in sore throat
patients at the time of extubation. Total live cells in TLF were
counted by trypan blue exclusion, and the number of neutrophils
were calculated by the product of live cells and percent abundance
of neutrophils as determined by FACS analysis using a neutrophils
Annexin V- SCChi CD66blo-hi CD16lo-hi gate for both tracheal
lavages. Results are shown as a mean SD derived from sore
throat patients (n¼ 13) and nonsore throat (n¼ 18) patients.
TLF: tracheal lavage fluid.
4 Molecular Pain
Sore throat TLF stimulates TLR9-dependent neutrophil
activation
To address the possibility that mtDNA in TLF drives
inﬂammatory mediator expression, we cocultured sore
throat and nonsore throat TLF with a HEK-293 reporter
cell line transfected with human TLR9 that measures
engagement of CpG DNA through stimulating alkaline
phosphatase transgene expression driven by the tran-
scription factors NF-kB and AP-122–24 (Figure 4). Sore
throat TLF was nearly ﬁve-fold better at stimulating
TLR9-mediated reporter activity when compared to
nonsore throat TLF. Pretreatment of sore throat TLF
with DNAse I or blockade with an iODN that inhibits
human TLR925 sharply reduced reporter activity.
We further asked if inﬂammatory mediator accumula-
tion in TLF from sore throat patients diﬀered from non-
sore throat patient TLF. Sore throat TLF had a
signiﬁcantly higher concentration of the proinﬂamma-
tory cytokines IL-1b, TNF-a, and IL-8 when compared
to TLF from nonsore throat patients (Figure 5(a)). In
line with these observations, sore throat TLF stimulated
accumulation of IL-1, TNF-, IL-8, and TLR9 mRNA
in neutrophils isolated from the peripheral blood of
healthy human volunteers (Figure 5(b)–(d)). Several
reports have shown that mtDNA triggers neutrophil
activation.14,26 To this end, we cocultured sore and
nonsore throat TLF with neutrophils isolated from
healthy human volunteer peripheral blood. Notably,
Figure 3. Elevated mitochondrial DNA concentration observed in sore throat patient TLF. (a) Mitochondrial DNA TLF and serum
concentrations were determined by real-time quantitative PCR analysis using cytochrome b primers and a cytochrome b standard
prepared from human lung mitochondria. (b) Bacterial 16S rRNA DNA levels measured by real-time semiquantiatitive PCR where the
quantitation cycle number (Cq) represents DNA levels. Data for (a) and (b) are a representative result of at least three independent
experiments. (c) Representative TLF neutrophil TLR9 levels shown as an overlaid histogram from a sore throat and a nonsore throat
patient where solid lines represent TLR9 staining and dotted lines represent isotype control staining. Results are shown as indicated mean
values SD for sore throat patients (n¼ 13) and nonsore throat (n¼ 18) patients.
TLF: tracheal lavage fluid.
Figure 4. Mitochondrial DNA in sore throat TLF stimulates
TLR9 signaling. A HEK 293 TLR9 reporter cell line was cultured
alone or coincubated with indicated TLFs left untreated or treated
with graded amounts of DNAse or TLR9 iODN. Six hours later,
supernatant was evaluated for target transgene NF-kB/AP-1 alka-
line phosphatase activity by fluorescence spectroscopy. Data are
shown as a representative result from three independent experi-
ments where mean alkaline phosphatase activity SD is calculated
from eight sore throat and eight nonsore throat patients.
HEK: human embryonic kidney; ODN: oligodeoxynucleotide;
TLF: tracheal lavage fluid.
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accumulation of these transcripts could be largely
reversed by pretreatment of sore throat TLF with
DNAse I or iODN. Moreover, we noted similar patterns
of TLR9-mediated neutrophil elastase activity and ROS
generation (Figure 6(a) and (b)). Taken together, these
data show that extracellular mtDNA in sore throat
patients stimulates neutrophil activation in a TLR9-
dependent manner.
Discussion
Sore throat pain is commonly reported following
ETT.1–3 Likewise, nearly half of our 31 patients reported
throat pain. Although the underlying mechanisms pro-
moting throat pain following ETT placement are yet to
be described, there is evidence that neutrophils may trig-
ger nociception.9–13,27 Previous work has shown that
depletion of neutrophils can prevent the induction of
Figure 5. Sore throat TLF has higher inflammatory cytokines and triggers neutrophil-mediated inflammatory cytokine expression in a
TLR9-dependent manner. TLF analyzed for (a) IL-1b, TNF-a, and chemokine IL-8 levels by enzyme-linked immunosorbent assay. Peripheral
blood neutrophils were incubated with indicated TLF, left untreated or treated with grade amounts of DNAse or TLR9 iODN, and 3 h later
fractionated for RNA and assessed for (b) IL-1 and TNF-, (c) IL-8, and (d) TLR9 transcripts by qPCR. Data are shown as a representative
result from at least four independent experiments where mean levels SD are normalized to uncultured freshly isolated neutrophils and
are derived from eight sore throat and eight nonsore throat patients.
iODN: inhibitory oligodeoxynucleotide; TLF: tracheal lavage fluid.
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hyperalgesia.28 The trachea is highly innervated with a
subepithelial network of peripheral nerves that express
transient receptor potential vanilloid calcium ion chan-
nels (TRPVs),29 which are well-established pain recep-
tors.30 Accordingly, we observed that neutrophilia was
signiﬁcantly greater in patients who reported sore throat
when compared to patients without sore throat.
Neutrophils of sore throat patients also constitutively
produced higher levels of ROS. Several studies have
shown that ROS directly promotes hyperalgesia in
both acute and inﬂammatory settings.12 In addition,
TLF of sore throat patients induced the release of
HNE, a mediator of neuropathic pain.9,10 Recent work
has revealed that neutrophil elastase generates pain
through the activation of protease-activated TRPV4
receptors on nociceptive neurons.10 Finally, we observed
higher levels of IL-1b and TNF-a gene transcription in
sore throat TLF-treated neutrophils, and similar secre-
tion of these cytokines, IL-1b and TNF-a, increases the
sensitivity of nociceptors by promoting TRPV1 activa-
tion.31 Taken together, these data show that TLF from
sore throat patients induce neutrophils to release signiﬁ-
cantly higher amounts of proinﬂammatory mediators
known to trigger peripheral nerve pain.
We also observed that neutrophils from patients with
ETT-mediated sore throat have a distinct activation
phenotype, which could be distinguished from patients
without sore throat by higher mean plasma membrane
expression of the adhesion molecules CD66b, CD11b,
and CD54. Importantly, high mean neutrophil adhesion
molecule expression has been observed in many disease
states.32–35 High mean CD66b expression has been
reported in the synovium of rheumatoid arthritis
patients,33 while elevated CD11b and CD54 levels have
been noted in inﬁltrating neutrophils of infectious or
ischemically injured tissue.34,35 In particular, elevated
CD11b expression may play a critical role in neutrophil
recruitment to the tracheal lumen as it is required for
both transendothelial and transepithelial migration.36,37
CD54, otherwise known as I-CAM1, binds to CD11b,
suggesting that sore throat neutrophils may additionally
promote inﬂammation by binding to each other or to
CD11b expressing myeloid cells such as macrophages.38
Therefore, these data suggest that ETT-mediated sore
throat is linked to the generation of a neutrophil pheno-
type with augmented ability to transmigrate tissue
barriers.
Neutrophil activation has primarily been described in
the context of infection.39 However, in sore throat
patients at the time of extubation, we detected high
levels of mtDNA in their TLF suggesting that neutrophil
inﬂammation was generated by sterile injury. As mito-
chondria encode genes that share considerable homology
with their bacterial ancestors, we considered the possibil-
ity that bacterial infection could be triggering neutrophil
activation in sore throat patients. TLF cultures revealed
only normal ﬂora in the throat irrespective of
whether they were derived from sore throat patients or
not (data not shown). In addition, there were nearly
undetectable levels of DNA that encode for the bacterial
16S ribosomal RNA in both sore throat and nonsore
throat patient TLF.
Figure 6. Sore throat TLF drives TLR9-mediated generation of ROS and elastase activity from neutrophils. Peripheral blood neutrophils
isolated from healthy human volunteers were incubated with indicated TLF left untreated or treated with graded amounts of DNAse I or
TLR9 iODN. One hour later, neutrophils were assessed for (a) human neutrophil elastase (HNE) activity by spectrophotometric assay and
(b) ROS by DHR 123 dye staining. Data are shown as a representative result from at least three independent experiments where mean
levels SD are derived from eight sore throat and eight nonsore throat patients.
DHR: dihydrorhodamine; HNE: human neutrophil elastase; iODN: inhibitory oligodeoxynucleotide; TLF: tracheal lavage fluid.
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The mechanism of mtDNA release was not directly
addressed in our study. However, in previous work by
our group, we observed in a pig model of ETT-mediated
inﬂammation tracheal histopathology consistent with
crush force-mediated epithelial injury.8 Indeed, others
have reported high levels of circulating extracellular
mtDNA released by blunt force tissue trauma.26 The
precise mechanisms by which mtDNA induces neutro-
phil activation remain unclear but appear to be depend-
ent on several related PRR pathways.40,41 Early studies
showed that bacterial-derived CpG DNA induces TLR9-
mediated NF-kB activation42 and IL-8 expression.43
Likewise, extracellular mtDNA has been demonstrated
to promote IL-8 expression in neutrophils.44 Later
reports have linked circulating mtDNA to neutrophil
superoxide production45 and the release of neutrophil
extracellular traps that may possibly contribute to the
additional release of mtDNA.46,47 mtDNA may also
augment neutrophilic inﬂammation in an indirect
manner via TLR9-mediated upregulation of adhesion
molecules on vascular endothelium, which increase neu-
trophil adherence and extravasation.48 In line with these
previous observations, mtDNA drove the transcription
and secretion of the ELR chemokine (CXCL8) IL-8 in
neutrophils. IL-8 is likely to promote the traﬃcking of
neutrophils into the trachea. We previously observed the
accumulation of IL-8 in TLF following ETT placement.8
Several reports have also shown that the expression of
the IL-8 cognate receptor CXCR2 on airway epithelium
and endothelium accentuates neutrophil recruitment.49,50
We next determined if TLR9 played a role in triggering
inﬂammatory gene expression in neutrophils from
patients with sore throat. To answer this question, we
used two independent approaches. First, we tested
TLR9 signaling activity in a HEK-293 reporter cell line
and demonstrated that sore throat TLF triggered NF-kB
and AP-1 driven gene expression. These results were in
line with previous observations showing that both tran-
scription factors are activated by CpG DNA stimulation
of TLR9 on neutrophils.22–24 DNAse I and iODN treat-
ment of sore throat TLF prevented TLR9 signaling, fur-
ther conﬁrming these results. Moreover, we observed
that this latter method inhibited sore throat TLF-
mediated inﬂammatory gene transcription, ROS, and
elastase release.
There are several limitations to this study. Although it
is clear that mtDNA in sore throat TLF led to most of
the observed neutrophil activation, nuclear DNA may
also be contributing to some inﬂammatory responses as
there are hypomethylated CpG motifs on active verte-
brate X chromosomes.51 Recent work has also suggested
that mtDNA may be generated by neutrophils.
Neutrophil extracellular traps, although predominantly
made up of nuclear chromatin, may also contain some
mtDNA.47
Here, we presented evidence that patients with sore
throat release mtDNA into their upper airway, which
is suﬃcient to drive TLR9-dependent neutrophil activa-
tion. Our observation that DNAse I inhibited neutrophil
activation may advance possible therapeutic interven-
tions aimed at mitigating local inﬂammation and subse-
quent pain stemming from sterile tissue injury. Longer
term studies of tracheal inﬂammation mediated by the
ETT will be needed to better understand if POST linked
to mtDNA also increases the risk of lower airway inﬂam-
mation or infection.
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